Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
16.50
Dollar change
+0.80
Percentage change
5.10
%
IndexRUT P/E- EPS (ttm)-0.49 Insider Own24.45% Shs Outstand43.67M Perf Week6.52%
Market Cap722.37M Forward P/E- EPS next Y-0.34 Insider Trans2.40% Shs Float33.07M Perf Month0.00%
Income-21.43M PEG- EPS next Q-0.14 Inst Own49.39% Short Float6.35% Perf Quarter122.37%
Sales84.82M P/S8.52 EPS this Y5.43% Inst Trans-3.47% Short Ratio5.18 Perf Half Y208.41%
Book/sh2.31 P/B7.14 EPS next Y26.70% ROA-15.91% Short Interest2.10M Perf Year444.55%
Cash/sh1.80 P/C9.19 EPS next 5Y- ROE-20.39% 52W Range2.96 - 20.90 Perf YTD141.94%
Dividend Est.- P/FCF- EPS past 5Y20.06% ROI-21.11% 52W High-21.05% Beta0.73
Dividend TTM- Quick Ratio5.27 Sales past 5Y37.03% Gross Margin86.54% 52W Low457.43% ATR (14)1.19
Dividend Ex-Date- Current Ratio5.52 EPS Y/Y TTM77.54% Oper. Margin-30.27% RSI (14)55.45 Volatility7.12% 7.42%
Employees100 Debt/Eq0.01 Sales Y/Y TTM29.96% Profit Margin-25.26% Recom1.86 Target Price20.00
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q-187.26% Payout- Rel Volume0.43 Prev Close15.70
Sales Surprise11.53% EPS Surprise89.80% Sales Q/Q-25.71% EarningsFeb 29 AMC Avg Volume405.64K Price16.50
SMA201.30% SMA5014.18% SMA200102.04% Trades Volume172,385 Change5.10%
Date Action Analyst Rating Change Price Target Change
May-10-23Upgrade Wedbush Neutral → Outperform $5 → $13
Apr-03-23Downgrade Guggenheim Buy → Neutral
Jan-27-23Downgrade Morgan Stanley Equal-Weight → Underweight $4
Jan-05-23Downgrade Cowen Outperform → Market Perform
Dec-02-22Downgrade BofA Securities Buy → Neutral $23 → $5
Dec-02-22Downgrade BofA Securities Buy → Neutral
Oct-31-22Downgrade Wedbush Outperform → Neutral $6
Oct-31-22Downgrade JP Morgan Neutral → Underweight $16 → $7
Jul-06-22Resumed Canaccord Genuity Buy $35
Jun-24-22Initiated BMO Capital Markets Outperform $27
Mar-20-24 07:37AM
Mar-14-24 09:05AM
Mar-12-24 09:55AM
Mar-05-24 12:00PM
Mar-04-24 08:45AM
07:30AM Loading…
07:30AM
Mar-01-24 09:42PM
Feb-29-24 05:25PM
04:37PM
04:05PM
Feb-22-24 10:00AM
Feb-16-24 07:30AM
Feb-13-24 04:10AM
Jan-02-24 04:05PM
Dec-13-23 04:05PM
01:05AM Loading…
Dec-12-23 01:05AM
Dec-03-23 03:04AM
Nov-30-23 11:04PM
Nov-15-23 01:14PM
01:33AM
Nov-13-23 05:31PM
05:25PM
04:05PM
Nov-08-23 12:00PM
Oct-31-23 07:05AM
Oct-18-23 04:05PM
Oct-17-23 04:05PM
Oct-16-23 04:05PM
Sep-21-23 04:05PM
Sep-06-23 04:05PM
09:55AM Loading…
Aug-23-23 09:55AM
Aug-13-23 06:25AM
Aug-10-23 05:15PM
04:05PM
Aug-02-23 04:05PM
Aug-01-23 04:05PM
Jul-26-23 12:35PM
Jun-02-23 03:15PM
May-26-23 09:00AM
09:00AM
May-23-23 09:00AM
May-18-23 06:39AM
May-13-23 08:18AM
May-10-23 06:14AM
02:52AM
May-08-23 05:15PM
04:01PM
May-01-23 10:01AM
Apr-28-23 09:00AM
Apr-18-23 09:00AM
Apr-17-23 10:57AM
Apr-05-23 07:44PM
09:55AM
09:00AM
Apr-04-23 05:12AM
Mar-30-23 05:25PM
04:01PM
02:42PM
Mar-21-23 04:01PM
Mar-15-23 10:22AM
Feb-20-23 10:00AM
Feb-16-23 10:01AM
07:57AM
Feb-02-23 09:00AM
Jan-05-23 10:34AM
Jan-04-23 04:01PM
Jan-03-23 09:00AM
Dec-21-22 09:00AM
Dec-16-22 04:01PM
Dec-14-22 09:00AM
Dec-08-22 09:00AM
Dec-07-22 09:19AM
Dec-06-22 09:00AM
Dec-01-22 05:34PM
Nov-07-22 05:15PM
04:01PM
Nov-02-22 04:01PM
Oct-31-22 03:01PM
08:52AM
05:34AM
Oct-28-22 03:33PM
Oct-06-22 09:34AM
Oct-03-22 09:00AM
Sep-29-22 02:53AM
Sep-26-22 09:00AM
Sep-09-22 08:35AM
Sep-01-22 04:05PM
Aug-30-22 09:00AM
Aug-13-22 08:29AM
Aug-08-22 05:45PM
04:05PM
Aug-02-22 09:00AM
Jul-12-22 09:00AM
Jun-30-22 07:31AM
May-31-22 09:00AM
May-26-22 04:01PM
May-09-22 05:25PM
04:01PM
May-03-22 04:01PM
Apr-28-22 03:02PM
Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gad ThomasCHIEF BUSINESS OFFICERMar 05 '24Sale16.443,90064,116158,700Mar 07 05:01 PM
Rajah VigneshSVP & CHIEF MEDICAL OFFICERMar 05 '24Sale16.531,71128,28333,889Mar 07 05:02 PM
Smith Susan LauraSVP & CHIEF COMMERCIAL OFFICERMar 05 '24Sale16.551,68227,83733,918Mar 07 04:59 PM
Gad ThomasChief Business OfficerDec 21 '23Option Exercise2.0050,000100,000140,500Dec 26 04:15 PM
Gad ThomasChief Business OfficerDec 15 '23Sale6.6150,000330,500265,032Dec 15 07:40 PM
Gad ThomasChief Business OfficerDec 14 '23Sale6.8350,000341,500315,032Dec 15 07:40 PM
Gad ThomasChief Business OfficerDec 13 '23Sale6.5850,000329,000365,032Dec 15 07:40 PM
Wedell-Wedellsborg JohanDirectorDec 11 '23Buy7.01102,863720,8434,552,778Dec 11 05:25 PM
WG Biotech ApSDirectorDec 11 '23Buy7.01102,863720,8434,552,778Dec 11 05:25 PM
Wedell-Wedellsborg JohanDirectorDec 11 '23Buy6.856,45544,2324,559,233Dec 12 08:26 AM
WG Biotech ApSDirectorDec 11 '23Buy6.856,45544,2324,559,233Dec 12 08:27 AM
WG Biotech ApSDirectorDec 08 '23Buy6.9918,503129,3794,449,915Dec 11 05:25 PM
Wedell-Wedellsborg JohanDirectorDec 08 '23Buy6.9918,503129,3794,449,915Dec 11 05:25 PM
Wedell-Wedellsborg JohanDirectorDec 07 '23Buy6.506,18340,1904,431,412Dec 11 05:25 PM
WG Biotech ApSDirectorDec 07 '23Buy6.506,18340,1904,431,412Dec 11 05:25 PM
Wedell-Wedellsborg JohanDirectorNov 29 '23Buy5.9751,837309,4774,425,229Dec 01 05:14 PM
WG Biotech ApSDirectorNov 29 '23Buy5.9751,837309,4774,425,229Dec 01 05:15 PM
Wedell-Wedellsborg JohanDirectorNov 28 '23Buy5.8130,671178,2754,373,392Nov 29 05:15 PM
WG Biotech ApSDirectorNov 28 '23Buy5.8130,671178,2754,373,392Nov 29 05:14 PM
WG Biotech ApSDirectorNov 27 '23Buy5.4962,516343,0194,342,721Nov 29 05:14 PM
Wedell-Wedellsborg JohanDirectorNov 27 '23Buy5.4962,516343,0194,342,721Nov 29 05:15 PM
Gad ThomasChief Business OfficerNov 21 '23Sale5.3175,000397,988415,032Nov 22 05:00 PM
Gad ThomasChief Business OfficerNov 20 '23Sale5.3075,000397,395490,032Nov 22 05:00 PM
Wedell-Wedellsborg JohanDirectorMay 15 '23Buy9.65101,740981,4044,280,205May 17 05:07 PM
WG Biotech ApSDirectorMay 15 '23Buy9.65101,740981,4044,280,205May 17 05:05 PM